Maxime Pedneault

Public health and prevention programs including the Public Health Agency of Canada and efforts to support the development and procurement of innovative vaccines and therapies to address major public health issues such as pandemic preparedness and RSV Federally-funded public drug plans, including the Non-Insured Health Benefits program, Canadian Armed Forces Drug Benefit List and veteran programs, with respect to reimbursement for drug products for beneficiaries Canada's Drug Agency policies and processes as it relates to reimbursement recommendation decision-making process and framework Engage with Canadian government officials to discuss and provide input on Canada’s countermeasures and policies in response to foreign tariffs affecting the pharmaceutical industry, as well as free trade agreements as they relate to the biopharmaceutical industry Establish accountability with Health Canada, Canada’s Drug Agency and the pan-Canadian Pharmaceutical Alliance, as well as Regulations, policies and programs related to the review and reimbursement processes Patented Medicines (Notice of Compliance) Regulations as it relates to the regulation of intellectual property for biopharmaceutical products Patent Act as it relates to reporting requirements and pricing guidelines, and the protection of intellectual property in biopharmaceutical products Policy measures to ensure security of drug supply in Canada and preserve Canada’s attractiveness for biopharmaceutical launches, including in response to foreign pricing regulations Policies and frameworks to accelerate access to innovative medicines post-Health Canada approval, including efforts to reduce time-to-reimbursement and streamline federal/provincial listing processes Biomanufacturing and Life Sciences Strategy (BLSS) as it relates to the biopharmaceutical industry Pharmaceutical pricing policy issues arising from the jurisdiction of the Patented Medicines Prices Review Board (PMPRB) Engagement with the Government regarding the Strategic Response Fund (SRF) (previously known as SIF) and investment in Canada Annual federal Budgets and Budget updates relating to the biopharmaceutical industry. Scientific Research and Experimental Development (SR&ED) Tax Incentive Program regarding eligible expenditures. Discussions on policies such as "patent box" and Investment Tax Credits.

Notice of Intent Surtax on China Steel & Aluminum under Section 53 Customs Tariff; International Trade - United States Surtax Orders 2025 under the Customs Tariff Act Communicating with Health Canada and the Public Health Agency of Canada (PHAC) in regard to the 2025 United Nations High-Level Meeting on Non-Communicable Diseases (NCDs), to inform discussions and to encourage Government of Canada alignment with the key principles of the World Health Organization (WHO) Global Strategy, WHO Global Alcohol Action Plan 2022-2030, and the UN 2018 Political Declaration on NCDs. Under the Excise Act, seeking the repeal of the automatic annual escalator on the federal excise duty and the introduction of new excise tiers with reduced rates for lower alcohol content beers. Safe Food for Canadians Regulations, pertaining to beer and alcoholic beverages. Importation of Intoxicating Liquors Act as it pertains to internal trade of beverage alcohol. Food & Drugs Act and Safe Food For Canadians Act as they pertain to the regulation of beer and alcoholic beverages. Food & Drug Regulations, pertaining to beer and alcoholic beverages. Federal Budget as it pertains to beverage alcohol taxation or regulation. Communicating on proposed restrictions on the use of certain single-use plastics. Communicating on beverage alcohol drinking guidance and labelling. Canadian Environmental Protection Act, 1999 as it pertains to use of certain single-use plastics.

Discuss Canadian Centre on Substance Use suggestions for safe drinking guidelines. Ensure gov't policy is based on more than one study. Responding to Finance Canada's countermeasures action against the United States in response to tariffs on Canadian steel and aluminum products. Advocating for exemption or other relief. Excise Escalator Tax. Advocating for repeal of the automatic annual escalator to the federal excise duty.